Pebblebrook Hotel Trust
PEB
$14.32
+1.49%
Pebblebrook Hotel Trust is a real estate investment trust (REIT) focused on owning and operating upper upscale and luxury hotels in the United States. The company's core narrative is its portfolio of primarily independent, non-branded hotels, supplemented by select properties under major hospitality brands, positioning it in the experiential luxury segment.…
PEB
Pebblebrook Hotel Trust
$14.32
Investment Opinion: Should I buy PEB Today?
Based on a synthesis of the technical strength, deeply discounted valuation, and concerning fundamentals, the objective assessment leans towards Hold. The stock is not a compelling Buy due to its lack of earnings and poor returns on capital. However, its low price-to-sales ratio and strong relative momentum suggest it is not a clear Sell either, but rather a speculative hold for investors betting on a sector recovery. The Synthesized Analyst Rating is Hold.
Sign up to view all
PEB 12-Month Price Forecast
The analysis yields a neutral stance. The valuation is cheap and momentum is positive, but these are counterbalanced by fundamental weaknesses in profitability and efficiency. The high beta adds significant uncertainty, making the stock a speculative play on economic cycles rather than a fundamental growth story.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Pebblebrook Hotel Trust's 12-month outlook, with a consensus price target around $18.62 and implied upside of +30.0% versus the current price.
Average Target
$18.62
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$11 - $19
Analyst target range
Wall Street analyst coverage for Pebblebrook Hotel Trust is limited, with only two analysts providing estimates. The consensus estimated EPS for the coming period is -$0.24, with a revenue estimate of approximately $1.49 billion. Recent institutional ratings from firms like Truist Securities and Wells Fargo are predominantly 'Hold' or 'Neutral', with one 'Outperform' from Baird and one 'Sell' from Compass Point. No consensus target price is available from the provided data.
Bulls vs Bears: PEB Investment Factors
PEB presents a mixed picture. Strong recent price momentum and a discounted valuation based on sales are positive, but these are overshadowed by persistent unprofitability and weak operational metrics. The stock's appeal hinges on a potential cyclical recovery in luxury travel.
Bullish
- Strong Relative Performance: Outperformed SPY by 15.5% over 6 months, showing resilience.
- Attractive Valuation Multiples: Trading at a low PS ratio of 0.90, suggesting a discount.
- Positive Free Cash Flow: Generated $223M in TTM FCF, providing financial flexibility.
- Portfolio in Luxury Segment: Focus on upper upscale and luxury hotels targets high-end demand.
Bearish
- Persistent Profitability Challenges: Negative net margin (-4.46%) and trailing EPS of -$0.05.
- Weak Operational Efficiency: Negative ROE (-2.67%) and low asset turnover (0.065).
- Liquidity Concerns: Current ratio of 0.70 indicates potential short-term obligations strain.
- High Beta and Cyclicality: Beta of 1.475 makes stock sensitive to economic downturns.
PEB Technical Analysis
Overall Assessment: The stock has demonstrated significant strength over the past six months, rising 12.67% from its price in early October 2025, significantly outperforming the broader market (SPY down 2.82% over the same period). The price has trended upward from the $10-11 range to recent levels above $12, indicating a positive intermediate-term trend.
Short-term Performance: Over the last month, the stock declined 1.56%, but this still represents a strong relative performance as the SPY fell 5.25% over the same period. The three-month performance is notably strong, with an 11.57% gain compared to a 4.63% decline for the SPY, highlighting its resilience and positive momentum.
Current Position: The current price of $12.63 sits near the upper end of its 52-week range of $7.41 to $13.35, approximately 94% of the 52-week high. This suggests the stock is trading at a relatively high level within its recent annual range, indicating strong investor confidence.
Beta
1.43
1.43x market volatility
Max Drawdown
-26.5%
Largest decline past year
52-Week Range
$9-$15
Price range past year
Annual Return
+59.1%
Cumulative gain past year
| Period | PEB Return | S&P 500 |
|---|---|---|
| 1m | +14.7% | +12.6% |
| 3m | +24.3% | +2.5% |
| 6m | +36.9% | +4.3% |
| 1y | +59.1% | +28.4% |
| ytd | +24.0% | +4.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PEB Fundamental Analysis
Revenue & Profitability: The company's most recent quarterly revenue (Q4 2025) was $349 million, representing a 3.38% year-over-year growth. However, profitability remains challenged, with a net loss of $17.85 million for the quarter and a negative trailing twelve-month net margin of -4.46%. The operating margin for the quarter was a positive 1.5%, showing some operational income generation.
Financial Health: The debt-to-equity ratio is 1.00, indicating a balanced capital structure between debt and equity. The current ratio is 0.70, suggesting potential liquidity constraints in covering short-term obligations with current assets. Free cash flow over the trailing twelve months is a positive $223 million, providing financial flexibility.
Operational Efficiency: Return on Equity (ROE) is negative at -2.67%, and Return on Assets (ROA) is a minimal 0.85%, indicating inefficient use of shareholder equity and company assets to generate profits. The asset turnover ratio from the latest quarter is low at 0.065, suggesting the company generates relatively little revenue per dollar of assets.
Quarterly Revenue
$349018000.0B
2025-12
Revenue YoY Growth
+0.03%
YoY Comparison
Gross Margin
-0.10%
Latest Quarter
Free Cash Flow
$223079000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PEB Overvalued?
Valuation Level: Given the company's negative net income, the Price-to-Sales (PS) ratio is the most appropriate valuation metric. The trailing PS ratio is 0.90, indicating the market values the company at less than one times its revenue. The forward-looking EV/Sales ratio is 2.61, which incorporates the company's enterprise value relative to sales.
Peer Comparison: Data not available for direct industry average comparisons. However, the low PS ratio of 0.90 suggests the market is applying a discounted valuation, likely reflecting the company's ongoing profitability challenges within the cyclical hotel REIT sector.
PE
-20.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -31x~503x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.1x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is fundamental: the company continues to operate at a net loss despite generating revenue, with a negative net margin and negative ROE indicating deep profitability issues. Financial health is a concern due to a low current ratio of 0.70, suggesting the company may struggle to meet short-term liabilities without selling assets or raising capital. As a hotel REIT with a high beta of 1.475, PEB is highly exposed to macroeconomic cycles, interest rate changes, and discretionary travel spending cuts. Limited analyst coverage (only 2 firms) and mixed institutional ratings (including a Sell) reduce visibility and consensus confidence in the turnaround story.
FAQ
Key risks include persistent unprofitability (negative ROE and net margin), liquidity concerns from a low current ratio of 0.70, and high sensitivity to economic cycles evidenced by a beta of 1.475. The company's fortunes are directly tied to discretionary luxury travel spending, which can decline rapidly in a downturn.
The 12-month outlook is range-bound with a neutral bias. The base case (60% probability) sees the stock trading between $11.50 and $13.00, as profitability challenges persist. A bull case could see a retest of the 52-week high near $13.35, while a bear case risks a fall towards the 52-week low of $7.41 if macro conditions worsen.
Based on sales, PEB appears undervalued with a trailing PS ratio of 0.90, meaning the market values it at less than its annual revenue. However, this discount is justified by its lack of earnings. Traditional P/E ratios are negative, so the valuation is cheap for a reason, reflecting significant business risk rather than a clear margin of safety.
PEB is not a clear-cut good buy based on fundamentals. While it trades at a discounted Price-to-Sales ratio of 0.90 and has shown strong relative momentum, it has not achieved consistent net profitability (TTM net margin -4.46%). It is best considered a speculative hold for investors with a high risk tolerance and a bullish view on the luxury travel cycle.
PEB is more suitable for a medium-term, tactical investment based on sector rotation or economic cycle timing, rather than a long-term buy-and-hold. Its lack of earnings and high volatility make it a poor fit for a long-term growth or income portfolio. Short-term trading is possible but risky due to its high beta.